|
Name |
Bipolarisorokin M
|
Molecular Formula | C33H48O5 | |
IUPAC Name* |
(7-formyl-1,6-dimethyl-4-propan-2-yl-8-bicyclo[3.2.1]oct-6-enyl)methyl4-(6-formyl-1,7-dimethyl-4-propan-2-yl-8-bicyclo[3.2.1]oct-6-enyl)-2-hydroxybut-3-enoate
|
|
SMILES |
CC1=C(C=O)C2C(C(C)C)CCC1(C)C2C=CC(O)C(=O)OCC1C2C(C=O)=C(C)C1(C)CCC2C(C)C
|
|
InChI |
InChI=1S/C33H48O5/c1-18(2)22-11-13-32(7)20(5)24(15-34)29(22)26(32)9-10-28(36)31(37)38-17-27-30-23(19(3)4)12-14-33(27,8)21(6)25(30)16-35/h9-10,15-16,18-19,22-23,26-30,36H,11-14,17H2,1-8H3/b10-9+/t22-,23-,26+,27+,28-,29-,30-,32+,33+/m1/s1
|
|
InChIKey |
MGHVTOSCVRSWKK-XKIRLSEPSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 524.74 | ALogp: | 6.1 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 80.7 | Aromatic Rings: | 4 |
Heavy Atoms: | 38 | QED Weighted: | 0.222 |
Caco-2 Permeability: | -4.953 | MDCK Permeability: | 0.00001380 |
Pgp-inhibitor: | 0.987 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.016 |
30% Bioavailability (F30%): | 0.873 |
Blood-Brain-Barrier Penetration (BBB): | 0.03 | Plasma Protein Binding (PPB): | 97.13% |
Volume Distribution (VD): | 0.953 | Fu: | 1.83% |
CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.542 |
CYP2C19-inhibitor: | 0.335 | CYP2C19-substrate: | 0.959 |
CYP2C9-inhibitor: | 0.271 | CYP2C9-substrate: | 0.048 |
CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.133 |
CYP3A4-inhibitor: | 0.854 | CYP3A4-substrate: | 0.908 |
Clearance (CL): | 8.298 | Half-life (T1/2): | 0.024 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.064 |
Drug-inuced Liver Injury (DILI): | 0.271 | AMES Toxicity: | 0.074 |
Rat Oral Acute Toxicity: | 0.388 | Maximum Recommended Daily Dose: | 0.808 |
Skin Sensitization: | 0.554 | Carcinogencity: | 0.374 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.02 |
Respiratory Toxicity: | 0.942 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005682 | 0.839 | D0G8OC | 0.230 | ||||
ENC005678 | 0.538 | D0G5CF | 0.227 | ||||
ENC005680 | 0.495 | D0Y7LD | 0.225 | ||||
ENC005687 | 0.436 | D06JPB | 0.221 | ||||
ENC005686 | 0.435 | D01CKY | 0.213 | ||||
ENC005679 | 0.422 | D0W5LS | 0.211 | ||||
ENC001779 | 0.387 | D0X4RS | 0.207 | ||||
ENC003555 | 0.367 | D04GJN | 0.206 | ||||
ENC005457 | 0.322 | D04SFH | 0.206 | ||||
ENC002278 | 0.307 | D04ATM | 0.204 |